News in brief - pp373 - 374

doi:10.1038/nbt0407-373

Full Text - News in brief | PDF (184 KB) - News in brief

Profile: John Maraganore - pp375 - 376

Brady Huggett

doi:10.1038/nbt0407-375

Abstract - Profile: John Maraganore | Full Text - Profile: John Maraganore | PDF (380 KB) - Profile: John Maraganore

Making money and opening minds - pp377 - 379

Monya Baker

doi:10.1038/nbt0407-377

Abstract - Making money and opening minds | Full Text - Making money and opening minds | PDF (173 KB) - Making money and opening minds

Billion dollar babies—biotech drugs as blockbusters - pp380 - 382

Stacy Lawrence

doi:10.1038/nbt0407-380

Abstract - Billion dollar babies[mdash]biotech drugs as blockbusters | Full Text - Billion dollar babies—biotech drugs as blockbusters | PDF (142 KB) - Billion dollar babies—biotech drugs as blockbusters | Supplementary information

Key ingredients for success in Europe - pp383 - 385

Colin Garner, Tony Marchington & Andrea Pfeifer

doi:10.1038/bioent917

PDF (557 KB) - Key ingredients for success in Europe

WARF's licensing policy for ES cell lines - pp387 - 388

Carl Gulbrandsen

doi:10.1038/nbt0407-387

Full Text - WARF's licensing policy for ES cell lines | PDF (1,376 KB) - WARF's licensing policy for ES cell lines

Gene patents—more evidence needed, but policymakers must act - pp388 - 389

E Richard Gold, Tania Bubela, Fiona A Miller, Dianne Nicol & Tina Piper

doi:10.1038/nbt0407-388

Full Text - Gene patents—more evidence needed, but policymakers must act | PDF (1,608 KB) - Gene patents—more evidence needed, but policymakers must act

Nanobiotech versus synthetic nanotech? - pp389 - 390

Mari Tabuchi

doi:10.1038/nbt0407-389

Full Text - Nanobiotech versus synthetic nanotech? | PDF (1,074 KB) - Nanobiotech versus synthetic nanotech?

Systems biology standards—the community speaks - pp390 - 391

Edda Klipp, Wolfram Liebermeister, Anselm Helbig, Axel Kowald & Jörg Schaber

doi:10.1038/nbt0407-390

Full Text - Systems biology standards—the community speaks | PDF (582 KB) - Systems biology standards—the community speaks | Supplementary information

Incentivizing standards development and adoption - pp391 - 392

Fiona Reddington, J Max Wilkinson, Robin Clark & Richard H Begent

doi:10.1038/nbt0407-391

Full Text - Incentivizing standards development and adoption | PDF (80 KB) - Incentivizing standards development and adoption

Commercializing cognitive neurotechnology—the ethical terrain - pp393 - 397

Margaret L Eaton & Judy Illes

doi:10.1038/nbt0407-393

Abstract - Commercializing cognitive neurotechnology[mdash]the ethical terrain | Full Text - Commercializing cognitive neurotechnology—the ethical terrain | PDF (1,089 KB) - Commercializing cognitive neurotechnology—the ethical terrain

Research sharing, ethics and public benefit - pp398 - 401

Patrick L Taylor

doi:10.1038/nbt0407-398

Abstract - Research sharing, ethics and public benefit | Full Text - Research sharing, ethics and public benefit | PDF (612 KB) - Research sharing, ethics and public benefit

Seduced by stem cells - p402

doi:10.1038/nbt0407-402

Full Text - Seduced by stem cells | PDF (83 KB) - Seduced by stem cells

The global stem cell patent landscape: implications for efficient technology transfer and commercial development - pp419 - 424

Karl Bergman & Gregory D. Graff

doi:10.1038/nbt0407-419

Abstract - The global stem cell patent landscape: implications for efficient technology transfer and commercial development | Full Text - The global stem cell patent landscape: implications for efficient technology transfer and commercial development | PDF (199 KB) - The global stem cell patent landscape: implications for efficient technology transfer and commercial development

Recent patent applications in proteomics - p425

doi:10.1038/nbt0407-425

Full Text - Recent patent applications in proteomics | PDF (42 KB) - Recent patent applications in proteomics

Overhauling the PDB - pp437 - 442

Amanda C Schierz, Larisa N Soldatova & Ross D King

doi:10.1038/nbt0407-437

Abstract - Overhauling the PDB | Full Text - Overhauling the PDB | PDF (1,252 KB) - Overhauling the PDB

Reporter proteins for in vivo fluorescence without oxygen - pp443 - 445

Thomas Drepper, Thorsten Eggert, Franco Circolone, Achim Heck, Ulrich Krau, Jan-Karl Guterl, Marion Wendorff, Aba Losi, Wolfgang Gärtner & Karl-Erich Jaeger

doi:10.1038/nbt1293

First paragraph - Reporter proteins for : in vivo: fluorescence without oxygen | Full Text - Reporter proteins for in vivo fluorescence without oxygen | PDF (167 KB) - Reporter proteins for in vivo fluorescence without oxygen | Supplementary information

Complete genome sequence of the erythromycin-producing bacterium Saccharopolyspora erythraea NRRL23338 - pp447 - 453

Markiyan Oliynyk, Markiyan Samborskyy, John B Lester, Tatiana Mironenko, Nataliya Scott, Shilo Dickens, Stephen F Haydock & Peter F Leadlay

doi:10.1038/nbt1297

Abstract - Complete genome sequence of the erythromycin-producing bacterium : Saccharopolyspora erythraea: NRRL23338 | Full Text - Complete genome sequence of the erythromycin-producing bacterium Saccharopolyspora erythraea NRRL23338 | PDF (1,336 KB) - Complete genome sequence of the erythromycin-producing bacterium Saccharopolyspora erythraea NRRL23338 | Supplementary information

See also: News and Views by Katz & Khosla

Bacterial glycosidases for the production of universal red blood cells - pp454 - 464

Qiyong P Liu, Gerlind Sulzenbacher, Huaiping Yuan, Eric P Bennett, Greg Pietz, Kristen Saunders, Jean Spence, Edward Nudelman, Steven B Levery, Thayer White, John M Neveu, William S Lane, Yves Bourne, Martin L Olsson, Bernard Henrissat & Henrik Clausen

doi:10.1038/nbt1298

Abstract - Bacterial glycosidases for the production of universal red blood cells | Full Text - Bacterial glycosidases for the production of universal red blood cells | PDF (525 KB) - Bacterial glycosidases for the production of universal red blood cells | Supplementary information

See also: News and Views by Daniels & Withers

An anti-infective peptide that selectively modulates the innate immune response - pp465 - 472

Monisha G Scott, Edie Dullaghan, Neeloffer Mookherjee, Natalie Glavas, Matthew Waldbrook, Annick Thompson, Aikun Wang, Ken Lee, Silvana Doria, Pam Hamill, Jie Jessie Yu, Yuexin Li, Oreola Donini, M Marta Guarna, B Brett Finlay, John R North & Robert E W Hancock

doi:10.1038/nbt1288

Abstract - An anti-infective peptide that selectively modulates the innate immune response | Full Text - An anti-infective peptide that selectively modulates the innate immune response | PDF (357 KB) - An anti-infective peptide that selectively modulates the innate immune response | Supplementary information

An expression atlas of rice mRNAs and small RNAs - pp473 - 477

Kan Nobuta, R C Venu, Cheng Lu, André Beló, Kalyan Vemaraju, Karthik Kulkarni, Wenzhong Wang, Manoj Pillay, Pamela J Green, Guo-liang Wang & Blake C Meyers

doi:10.1038/nbt1291

First paragraph - An expression atlas of rice mRNAs and small RNAs | Full Text - An expression atlas of rice mRNAs and small RNAs | PDF (286 KB) - An expression atlas of rice mRNAs and small RNAs | Supplementary information

See also: News and Views by Rafalski

Erratum: Live dynamic imaging of caveolae pumping targeted antibody rapidly and specifically across endothelium in the lung - p478

Phil Oh, Per Borgström, Halina Witkiewicz, Yan Li, Bengt J Borgström, Adrian Chrastina, Koji Iwata, Kurt R Zinn, Richard Baldwin, Jacqueline E Testa & Jan E Schnitzer

doi:10.1038/nbt0407-478a

Full Text - Erratum: Live dynamic imaging of caveolae pumping targeted antibody rapidly and specifically across endothelium in the lung | PDF (66 KB) - Erratum: Live dynamic imaging of caveolae pumping targeted antibody rapidly and specifically across endothelium in the lung

Erratum: Incretin mimetics vie for slice of type 2 diabetes market - p478

Catherine Shaffer

doi:10.1038/nbt0407-478b

Full Text - Erratum: Incretin mimetics vie for slice of type 2 diabetes market | PDF (66 KB) - Erratum: Incretin mimetics vie for slice of type 2 diabetes market

Erratum: Editorial. Bioethanol needs biotech now - p478

doi:10.1038/nbt0407-478c

Full Text - Erratum: Editorial. Bioethanol needs biotech now | PDF (66 KB) - Erratum: Editorial. Bioethanol needs biotech now

Corrigendum: Complete genome of the mutualistic, N₂-fixing grass endophyte Azoarcus sp. strain BH72 - p478

Andrea Krause, Adarsh Ramakumar, Daniela Bartels, Federico Battistoni, Thomas Bekel, Jens Boch, Melanie Böhm, Frauke Friedrich, Thomas Hurek, Lutz Krause, Burkhard Linke, Alice C McHardy, Abhijit Sarkar, Susanne Schneiker, Arshad Ali Syed, Rudolf Thauer, Frank-Jörg Vorhölter, Stefan Weidner, Alfred Pühler, Barbara Reinhold-Hurek, Olaf Kaiser & Alexander Goesmann

doi:10.1038/nbt0407-478d

Full Text - Corrigendum: Complete genome of the mutualistic, N2-fixing grass endophyte Azoarcus sp. strain BH72 | PDF (66 KB) - Corrigendum: Complete genome of the mutualistic, N2-fixing grass endophyte Azoarcus sp. strain BH72

Corrigendum: Genome sequence of the bioplastic-producing "Knallgas" bacterium Ralstonia eutropha H16 - p478

Anne Pohlmann, Wolfgang Florian Fricke, Frank Reinecke, Bernhard Kusian, Heiko Liesegang, Rainer Cramm, Thomas Eitinger, Christian Ewering, Markus Pötter, Edward Schwartz, Axel Strittmatter, Ingo Vo, Gerhard Gottschalk, Alexander Steinbüchel, Bärbel Friedrich & Botho Bowien

doi:10.1038/nbt0407-478e

Full Text - Corrigendum: Genome sequence of the bioplastic-producing "Knallgas" bacterium Ralstonia eutropha H16 | PDF (66 KB) - Corrigendum: Genome sequence of the bioplastic-producing "Knallgas" bacterium Ralstonia eutropha H16

Corrigendum: Evolving symbiosis—venture capital and biotechnology - p478

Terry C Bradford

doi:10.1038/nbt0407-478f

Full Text - Corrigendum: Evolving symbiosis—venture capital and biotechnology | PDF (66 KB) - Corrigendum: Evolving symbiosis—venture capital and biotechnology

Managing change in biotech: startup and growth - pp479 - 480

Mary Ann Rafferty

doi:10.1038/nbt0407-479

Abstract - Managing change in biotech: startup and growth | Full Text - Managing change in biotech: startup and growth | PDF (71 KB) - Managing change in biotech: startup and growth

People - p482

doi:10.1038/nbt0407-482

Full Text - People | PDF (241 KB) - People